{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:15:10Z","timestamp":1773933310670,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clgc.2025.102424","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:24:41Z","timestamp":1756509881000},"page":"102424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Treatment Patterns and Outcomes Among Patients Diagnosed With Nonmuscle-Invasive Bladder Cancer in the United States"],"prefix":"10.1016","volume":"24","author":[{"given":"Bernard Bright","family":"Davies-Teye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6005-4690","authenticated-orcid":false,"given":"Dominique","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abree","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Burcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5755-5910","authenticated-orcid":false,"given":"Nader","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8547-1810","authenticated-orcid":false,"given":"Eberechukwu","family":"Onukwugha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Minhaj","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102424_bib0001","series-title":"Bladder cancer","year":"2023"},{"issue":"1","key":"10.1016\/j.clgc.2025.102424_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Medical Sciences"},{"key":"10.1016\/j.clgc.2025.102424_bib0003","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer: https:\/\/gco.iarc.who.int\/today."},{"key":"10.1016\/j.clgc.2025.102424_bib0004","series-title":"Key statistics for bladder cancer","year":"2025"},{"issue":"1","key":"10.1016\/j.clgc.2025.102424_bib0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clgc.2025.102424_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Nat Compreh Can Netw"},{"issue":"6","key":"10.1016\/j.clgc.2025.102424_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.clgc.2025.102424_bib0008","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"issue":"28","key":"10.1016\/j.clgc.2025.102424_bib0009","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1200\/JCO.2022.40.28_suppl.404","article-title":"Real-world treatment patterns among patients with non-muscle invasive bladder cancer (NMIBC) treated with intravesical Bacillus Calmette-Guerin (BCG)","volume":"40","author":"Kumar","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102424_bib0010","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2019.905","article-title":"The use of intravesical BCG in urothelial carcinoma of the bladder","volume":"13","author":"Alhunaidi","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.clgc.2025.102424_bib0011","unstructured":"About the National Cancer Database | ACS. Accessed January 31, 2024. https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/about\/"},{"issue":"6","key":"10.1016\/j.clgc.2025.102424_bib0012","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamasurg.2023.0652","article-title":"Disruption of national cancer database data models in the first year of the COVID-19 Pandemic","volume":"158","author":"Lum","year":"2023","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.clgc.2025.102424_bib0013","doi-asserted-by":"crossref","DOI":"10.21037\/tau-22-43","article-title":"Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes","volume":"11","author":"Ogbue","year":"2022","journal-title":"Translational Andrology and Urology"},{"key":"10.1016\/j.clgc.2025.102424_bib0014","series-title":"Invasive urothelial carcinoma","author":"Durowoju","year":"2021"},{"issue":"3","key":"10.1016\/j.clgc.2025.102424_bib0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4103\/2249-4863.197258","article-title":"Urinary tract cancers: an overview for general practice","volume":"5","author":"Yaxley","year":"2016","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.clgc.2025.102424_bib0016","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102424_bib0017","unstructured":"American College of Surgeons. Participant User Files. National Cancer Database. Chicago, IL: American College of Surgeons. Available from: https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/puf\/. Accessed September 16, 2025."},{"issue":"1","key":"10.1016\/j.clgc.2025.102424_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.juro.2016.02.3005","article-title":"Immunotherapy for the treatment of urothelial carcinoma","volume":"197","author":"DN","year":"2017","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102424_bib0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11912-022-01350-9","article-title":"Novel therapies for high-risk non-muscle invasive bladder cancer","volume":"25","author":"Al Hussein Al Awamlh","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clgc.2025.102424_bib0020","unstructured":"National Cancer Database (NCDB). National Cancer Database Participant User File 2017 Data Dictionary. Chicago, IL: American College of Surgeons; 2020."},{"key":"10.1016\/j.clgc.2025.102424_bib0021","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102424_bib0022","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"13","key":"10.1016\/j.clgc.2025.102424_bib0023","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3390\/cancers14133073","article-title":"BCG in bladder cancer immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2025.102424_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urology.2020.05.023","article-title":"High-risk nonmuscle invasive bladder cancer: selecting the appropriate patient for timely cystectomy","volume":"147","author":"Koch","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2025.102424_bib0026","series-title":"An update on the supply and production of Bacille Calmette-Gu\u00e9rin","author":"Awamlh","year":"2023"},{"issue":"13","key":"10.1016\/j.clgc.2025.102424_bib0027","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.3390\/cancers14133181","article-title":"Advances in diagnosis and therapy for bladder cancer","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.clgc.2025.102424_bib0028","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/iju.15263","article-title":"Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: evidence update of surgical concept, risk stratification, and BCG-treated disease","volume":"30","author":"Miyake","year":"2023","journal-title":"Int J Urol"},{"issue":"10","key":"10.1016\/j.clgc.2025.102424_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/bios12100796","article-title":"State-of-the-art advances of nanomedicine for diagnosis and treatment of bladder cancer","volume":"12","author":"Kong","year":"2022","journal-title":"Biosensors"},{"issue":"3","key":"10.1016\/j.clgc.2025.102424_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bju.13760","article-title":"Guideline of guidelines \u2013 Non-muscle invasive bladder cancer","volume":"119","author":"Woldu","year":"2017","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2025.102424_bib0031","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/JU.0000000000002941","article-title":"Patient and provider perception of transurethral resection of bladder tumor vs chemoablation for nonmuscle-invasive bladder cancer treatment","volume":"209","author":"Taylor","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102424_bib0032","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.euros.2022.12.016","article-title":"Patient preferences for treatment of Bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle-invasive bladder cancer: A cross-country choice experiment","volume":"49","author":"Collacott","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"10.1016\/j.clgc.2025.102424_bib0033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/UPJ.0000000000000481","article-title":"US clinical practice patterns of intravesical chemotherapy for Bacillus Calmette-Gu\u00e9rin\u2013Unresponsive and Bacillus Calmette-Gu\u00e9rin\u2013Exposed nonmuscle-invasive bladder cancer","volume":"11","author":"Mohamad","year":"2024","journal-title":"Urol Pract"},{"issue":"1","key":"10.1016\/j.clgc.2025.102424_bib0034","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12967-023-04528-2","article-title":"Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional study","volume":"21","author":"Zheng","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.clgc.2025.102424_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1301510","article-title":"HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion in EORTC risk-stratified cohort of bladder cancer","volume":"14","author":"Nam","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.clgc.2025.102424_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.947446","article-title":"Non-muscle invasive bladder cancer biomarkers beyond morphology","volume":"12","author":"De Carlo","year":"2022","journal-title":"Front Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:50:59Z","timestamp":1773924659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1558767325001247"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102424","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Treatment Patterns and Outcomes Among Patients Diagnosed With Nonmuscle-Invasive Bladder Cancer in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates and The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102424"}}